Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0002 Transporter Info | ||||
Gene Name | ABCC2 | ||||
Transporter Name | Multidrug resistance-associated protein 2 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
CEBPB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to ABCC2 gene | [1] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein beta | Transcription Factor Info | ||||
Tissue |
Bone | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein beta (CEBPB) can directly bind to the ABCC2 gene, which in turn affects the expression or function of the drug transporter Multidrug resistance-associated protein 2. | |||||
JUN |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to ABCC2 gene in coronary artery disease condition | [2] | ||||
TF Protein Name |
Transcription factor Jun | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor Jun (JUN) has been reported to bind to the ABCC2 gene in coronary artery disease condition, which in turn affects the expression or function of the drug transporter Multidrug resistance-associated protein 2. | |||||
JUND |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to ABCC2 gene in coronary artery disease condition | [2] | ||||
TF Protein Name |
Transcription factor JunD | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor JunD (JUND) has been reported to bind to the transcription of ABCC2 gene in coronary artery disease condition, which leads to an affected expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
NFE2L2 |
Click to Show/Hide to Show 5 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of ABCC2 gene in health condition | [3] | ||||
TF Protein Name |
Nuclear factor erythroid 2-related factor 2 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Arsenic | |||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Liver | |||||
Related DT Changes |
up regulating | |||||
Experimental Material |
Human hepatocytes | |||||
Detailed Description |
Nuclear factor erythroid 2-related factor 2 (NFE2L2), influenced by the exogenous arsenic, has been reported to activate the transcription of ABCC2 gene in health condition , which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Transcriptional Phenomenon2 |
Activation of ABCC2 gene in hepatoblastoma condition | [4] | ||||
TF Protein Name |
Nuclear factor erythroid 2-related factor 2 | Transcription Factor Info | ||||
Studied Phenotype |
Hepatoblastoma [ICD11: 2C12.01] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human hepatoblastoma cells (HepG2) | |||||
Detailed Description |
Nuclear factor erythroid 2-related factor 2 (NFE2L2) has been reported to activate the transcription of ABCC2 gene in hepatoblastoma condition, which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Transcriptional Phenomenon3 |
Activation of ABCC2 gene in health condition | [5] | ||||
TF Protein Name |
Nuclear factor erythroid 2-related factor 2 | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Liver | |||||
Related DT Changes |
up regulating | |||||
Experimental Material |
C57/B6 mice | |||||
Detailed Description |
Nuclear factor erythroid 2-related factor 2 (NFE2L2), influenced by the exogenous arsenic, has been reported to activate the transcription of ABCC2 gene in health condition , which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Transcriptional Phenomenon4 |
Activation of ABCC2 gene in brain neuroblastoma condition | [6] | ||||
TF Protein Name |
Nuclear factor erythroid 2-related factor 2 | Transcription Factor Info | ||||
Studied Phenotype |
Brain neuroblastoma [ICD11: 2A00.11] | |||||
Tissue |
Brain | |||||
Related DT Changes |
up regulating | |||||
Experimental Material |
Human neuroblastoma cells (SH-SY5Y) | |||||
Detailed Description |
Nuclear factor erythroid 2-related factor 2 (NFE2L2), influenced by the exogenous arsenic, has been reported to activate the transcription of ABCC2 gene in brain neuroblastoma condition , which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Transcriptional Phenomenon5 |
Activation of ABCC2 gene in health condition | [7] | ||||
TF Protein Name |
Nuclear factor erythroid 2-related factor 2 | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
C57BL/6 mice | |||||
Detailed Description |
Nuclear factor erythroid 2-related factor 2 (NFE2L2) has been reported to activate the transcription of ABCC2 gene in health condition, which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Class1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
AHR |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of ABCC2 gene in health condition | [7] | ||||
TF Protein Name |
Aryl hydrocarbon receptor | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
C57BL/6 mice | |||||
Detailed Description |
Aryl hydrocarbon receptor (AHR) has been reported to activate the transcription of ABCC2 gene in health condition, which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
MITF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of ABCC2 gene in melanoma condition | [8] | ||||
TF Protein Name |
Microphthalmia-associated transcription factor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Microphthalmia-associated transcription factor (MITF) has been reported to activate the transcription of ABCC2 gene in melanoma condition, which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
TCF21 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to ABCC2 gene in coronary artery disease condition | [2] | ||||
TF Protein Name |
Transcription factor 21 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor 21 (TCF21) has been reported to bind to the ABCC2 gene in coronary artery disease condition, which in turn affects the expression or function of the drug transporter Multidrug resistance-associated protein 2. | |||||
Class2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 7 TF(s) Regulating This DT |
|||||
AR |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to ABCC2 gene in prostate cancer condition | [9] | ||||
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Androgen receptor (AR) has been reported to bind to the transcription of ABCC2 gene in prostate cancer condition, which leads to an affected expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
ESR1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of ABCC2 gene in breast cancer condition | [10] | ||||
TF Protein Name |
Estrogen receptor | Transcription Factor Info | ||||
Studied Phenotype |
Breast cancer [ICD11: 2C60-2C6Z] | |||||
Tissue |
Breast | |||||
Related DT Changes |
down regulating | |||||
Experimental Material |
Human breast carcinoma cells (MCF-7) | |||||
Detailed Description |
Estrogen receptor (ESR1), influenced by the exogenous fulvestrant, has been reported to repress the transcription of ABCC2 gene in breast cancer condition , which leads to a decreased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
HNF4A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to ABCC2 gene | [11] | ||||
TF Protein Name |
Hepatocyte nuclear factor 4-alpha | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 4-alpha (HNF4A) can directly bind to the ABCC2 gene, which in turn affects the expression or function of the drug transporter Multidrug resistance-associated protein 2. | |||||
NR1H4 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of ABCC2 gene in hepatoblastoma condition | [12] | ||||
TF Protein Name |
Bile acid receptor | Transcription Factor Info | ||||
Studied Phenotype |
Hepatoblastoma [ICD11: 2C12.01] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human hepatoblastoma cells (HepG2) | |||||
Detailed Description |
Bile acid receptor (NR1H4) has been reported to activate the transcription of ABCC2 gene in hepatoblastoma condition, which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Transcriptional Phenomenon2 |
Activation of ABCC2 gene in health condition | [13] | ||||
TF Protein Name |
Bile acid receptor | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Liver | |||||
Related DT Changes |
up regulating | |||||
Experimental Material |
Male mice | |||||
Detailed Description |
Bile acid receptor (NR1H4), influenced by the exogenous lithocholic acid, has been reported to activate the transcription of ABCC2 gene in health condition , which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
NR1I2 |
Click to Show/Hide to Show 6 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of ABCC2 gene in hepatoblastoma condition | [12] | ||||
TF Protein Name |
Nuclear receptor subfamily 1 group I member 2 | Transcription Factor Info | ||||
Studied Phenotype |
Hepatoblastoma [ICD11: 2C12.01] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human hepatoblastoma cells (HepG2) | |||||
Detailed Description |
Nuclear receptor subfamily 1 group I member 2 (NR1I2) has been reported to activate the transcription of ABCC2 gene in hepatoblastoma condition, which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Transcriptional Phenomenon2 |
Activation of ABCC2 gene in cholestatic liver disease condition | [14] | ||||
TF Protein Name |
Nuclear receptor subfamily 1 group I member 2 | Transcription Factor Info | ||||
Studied Phenotype |
Cholestatic liver disease [ICD11: DB99] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
C57BL/6 mice | |||||
Detailed Description |
Nuclear receptor subfamily 1 group I member 2 (NR1I2) has been reported to activate the transcription of ABCC2 gene in cholestatic liver disease condition, which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Transcriptional Phenomenon3 |
Activation of ABCC2 gene in health condition | [15] | ||||
TF Protein Name |
Nuclear receptor subfamily 1 group I member 2 | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Liver | |||||
Related DT Changes |
up regulating | |||||
Experimental Material |
C57BL/6 mice | |||||
Detailed Description |
Nuclear receptor subfamily 1 group I member 2 (NR1I2), influenced by the exogenous resveratrol, has been reported to activate the transcription of ABCC2 gene in health condition , which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Transcriptional Phenomenon4 |
Activation of ABCC2 gene in hepatocellular carcinoma condition | [16] | ||||
TF Protein Name |
Nuclear receptor subfamily 1 group I member 2 | Transcription Factor Info | ||||
Studied Phenotype |
Hepatocellular carcinoma [ICD11: 2C12.02] | |||||
Tissue |
Liver | |||||
Related DT Changes |
up regulating | |||||
Experimental Material |
Human hepatocellular carcinoma (HepaRG) | |||||
Detailed Description |
Nuclear receptor subfamily 1 group I member 2 (NR1I2), influenced by the exogenous resveratrol, has been reported to activate the transcription of ABCC2 gene in hepatocellular carcinoma condition , which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Transcriptional Phenomenon5 |
Activation of ABCC2 gene in bile duct obstruction condition | [17] | ||||
TF Protein Name |
Nuclear receptor subfamily 1 group I member 2 | Transcription Factor Info | ||||
Studied Phenotype |
Bile duct obstruction [DC10.02] | |||||
Tissue |
Liver | |||||
Related DT Changes |
up regulating | |||||
Experimental Material |
Wistar rats | |||||
Detailed Description |
Nuclear receptor subfamily 1 group I member 2 (NR1I2), influenced by the exogenous resveratrol, has been reported to activate the transcription of ABCC2 gene in bile duct obstruction condition , which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Transcriptional Phenomenon6 |
Activation of ABCC2 gene in health condition | [18] | ||||
TF Protein Name |
Nuclear receptor subfamily 1 group I member 2 | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Duodenum | |||||
Related DT Changes |
up regulating | |||||
Experimental Material |
Human duodenal mucosa biopsy specimens | |||||
Detailed Description |
Nuclear receptor subfamily 1 group I member 2 (NR1I2), influenced by the exogenous resveratrol, has been reported to activate the transcription of ABCC2 gene in health condition , which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
NR1I3 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of ABCC2 gene in hepatoblastoma condition | [19] | ||||
TF Protein Name |
Nuclear receptor subfamily 1 group I member 3 | Transcription Factor Info | ||||
Studied Phenotype |
Hepatoblastoma [ICD11: 2C12.01] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human hepatoblastoma cells (HepG2) | |||||
Detailed Description |
Nuclear receptor subfamily 1 group I member 3 (NR1I3) has been reported to activate the transcription of ABCC2 gene in hepatoblastoma condition, which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Transcriptional Phenomenon2 |
Activation of ABCC2 gene in health condition | [7] | ||||
TF Protein Name |
Nuclear receptor subfamily 1 group I member 3 | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
C57BL/6 mice | |||||
Detailed Description |
Nuclear receptor subfamily 1 group I member 3 (NR1I3) has been reported to activate the transcription of ABCC2 gene in health condition, which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
PPARA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of ABCC2 gene in health condition | [20] | ||||
TF Protein Name |
Peroxisome proliferator-activated receptor alpha | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Brain | |||||
Related DT Changes |
up regulating | |||||
Experimental Material |
Sprague Dawley rats | |||||
Detailed Description |
Peroxisome proliferator-activated receptor alpha (PPARA), influenced by the exogenous perfluorooctane sulfonic acid, has been reported to activate the transcription of ABCC2 gene in health condition , which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Class2.2: Other C4 zinc finger-type factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
GATA3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to ABCC2 gene in breast cancer condition | [21] | ||||
TF Protein Name |
Trans-acting T-cell-specific transcription factor GATA-3 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Trans-acting T-cell-specific transcription factor GATA-3 (GATA3) has been reported to bind to the transcription of ABCC2 gene in breast cancer condition, which leads to an affected expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
GATA4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of ABCC2 gene in gastric cancer condition | [22] | ||||
TF Protein Name |
Transcription factor GATA-4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor GATA-4 (GATA4) has been reported to activate the transcription of ABCC2 gene in gastric cancer condition, which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
GATA6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of ABCC2 gene in gastric cancer condition | [22] | ||||
TF Protein Name |
Transcription factor GATA-6 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor GATA-6 (GATA6) has been reported to activate the transcription of ABCC2 gene in gastric cancer condition, which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Class3.1: Homeo domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
HNF1A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of ABCC2 gene in sepsis condition | [23] | ||||
TF Protein Name |
Hepatocyte nuclear factor 1-alpha | Transcription Factor Info | ||||
Studied Phenotype |
Sepsis [ICD11: 1G40-1G41] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
C57BL/6 mice | |||||
Detailed Description |
Hepatocyte nuclear factor 1-alpha (HNF1A) has been reported to activate the transcription of ABCC2 gene in sepsis condition, which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
ONECUT1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of ABCC2 gene in health condition | [24] | ||||
TF Protein Name |
Hepatocyte nuclear factor 6 | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Mouse liver hepatic sinusoidal endothelial cells (SV40LG) | |||||
Detailed Description |
Hepatocyte nuclear factor 6 (ONECUT1) has been reported to activate the transcription of ABCC2 gene in health condition, which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Class3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
FOXA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to ABCC2 gene | [25] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Tissue |
Breast; Liver; Lung; Pancreatic ductal; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) can directly bind to the ABCC2 gene, which in turn affects the expression or function of the drug transporter Multidrug resistance-associated protein 2. | |||||
FOXA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to ABCC2 gene in health condition | [11] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) has been reported to bind to the transcription of ABCC2 gene in health condition, which leads to an affected expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Class3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
IRF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of ABCC2 gene in hepatoblastoma condition | [26] | ||||
TF Protein Name |
Interferon regulatory factor 3 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Actinomycin D | |||||
Studied Phenotype |
Hepatoblastoma [ICD11: 2C12.01] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human hepatoblastoma cells (HepG2) | |||||
Detailed Description |
Interferon regulatory factor 3 (IRF3) has been reported to activate the transcription of ABCC2 gene in hepatoblastoma condition, which leads to an increased expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
SPI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to ABCC2 gene | [27] | ||||
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Brain; Breast; Embryo; Foreskin; Intestine; Kidney; Lung; Muscle; Penis; Placenta; Renal cortex; Renal pelvis; Skin; Umbilical cord blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor PU.1 (SPI1) can directly bind to the ABCC2 gene, which in turn affects the expression or function of the drug transporter Multidrug resistance-associated protein 2. | |||||
Class6.3: p53 domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
TP63 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to ABCC2 gene in health condition | [28] | ||||
TF Protein Name |
Tumor protein 63 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Tumor protein 63 (TP63) has been reported to bind to the transcription of ABCC2 gene in health condition, which leads to an affected expression of the drug transporter Multidrug resistance-associated protein 2. | |||||
Class6.7: Grainyhead domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GRHL2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to ABCC2 gene | [29] | ||||
TF Protein Name |
Grainyhead-like protein 2 homolog | Transcription Factor Info | ||||
Tissue |
Breast; Bronchus; Ovary | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Grainyhead-like protein 2 homolog (GRHL2) can directly bind to the ABCC2 gene, which in turn affects the expression or function of the drug transporter Multidrug resistance-associated protein 2. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.